清肺饮加味联合参麦注射液治疗痰湿阻肺型慢性阻塞性肺疾病伴肺部感染临床研究
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R563

基金项目:


Clinical Study on Modified Qingfei Yin Combined with Shenmai Injection for COPD of Phlegm-Dampness Obstructing the Lung Type Complicated with Pulmonary Infection
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察清肺饮加味联合参麦注射液治疗痰湿阻肺型慢性阻塞性肺疾病(COPD) 伴肺部感染的临床疗效。方法:选取COPD 伴肺部感染患者82 例,按随机数字表法分为对照组和治疗组各41 例。2 组均予常规干预措施,对照组加用参麦注射液治疗,治疗组在对照组的基础上加用清肺饮加味内服。2 组均连续治疗10 d。比较2 组肺部感染评分(CPIS)、肺功能[用力肺活量(FVC)、第1 秒钟用力呼吸量(FEV1)、FEV1/FVC] 以及总体临床疗效。结果:治疗组总有效率为95.12%,对照组为75.61%,2 组比较,差异有统计学意义(P<0.05)。治疗后,2 组CPIS 评分较治疗前明显降低(P<0.05),且治疗组CPIS 评分明显低于对照组(P<0.05);2 组FVC、FEV1、FEV1/FVC 水平均较治疗前明显升高(P<0.05),且治疗组上述指标均明显高于对照组(P<0.05)。结论:清肺饮加味联合参麦注射液治疗痰湿阻肺型COPD 伴肺部感染疗效显著,可减少患者肺部感染,改善肺功能。

    Abstract:

    Abstract: Objective: To observe the clinical effect of modified Qingfei yin combined with Shenmai injection for chronic obstructive pulmonary disease(COPD) of phlegm-dampness obstructing the lung type complicated with pulmonary infection. Methods: A total of 82 cases of patients with COPD complicated with pulmonary infection were selected and divided into the control group and the treatment group according to the random number table method, with 41 cases in each group. Both groups were given routine intervention;the control group was additionally treated with Shenmai injection,and the treatment group was additionally given the oral administration of Qingfei yin based on the treatment of the control group. Both groups were treated for ten days. The Clinical Pulmonary Infection Score(CPIS), the lung function including forced vital capacity(FVC), forced expiratory volume in the first second(FEV1) and FEV1/ FVC,and the total clinical effects in the two groups were compared. Results:The total effective rate was 95.12% in the treatment group and 75.61% in the control group,the difference being significant(P<0.05). After treatment,CPIS scores in the two groups were significantly decreased when compared with those before treatment(P<0.05),and CPIS score in the treatment group was significantly lower than that in the control group(P<0.05). After treatment, FVC, FEV1 and FEV1/FVC in the two groups were significantly increased when compared with those before treatment(P<0.05),and the above indexes in the treatment group were significantly higher than those in the control group(P<0.05). Conclusion: The therapy of modified Qingfei yin combined with Shenmai injection has a significant curative effect in the treatment of patients with COPD of phlegm-dampness obstructing the lung type complicated with pulmonary infection, which can reduce lung infection and improve lung function.

    参考文献
    相似文献
    引证文献
引用本文

赵纯,张成明,管养洪.清肺饮加味联合参麦注射液治疗痰湿阻肺型慢性阻塞性肺疾病伴肺部感染临床研究[J].新中医,2022,54(16):36-39

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-08-28
  • 出版日期: